234 related articles for article (PubMed ID: 6208430)
1. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
Tasaka K; Akagi M; Izushi K; Mio M
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
[TBL] [Abstract][Full Text] [Related]
4. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 3rd communication: inhibitory effects on histamine release from lung fragments, Schultz-Dale reaction in isolated tracheal muscle and experimental asthma in guinea pigs.
Yanagihara Y; Abe T; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):80-3. PubMed ID: 2452640
[TBL] [Abstract][Full Text] [Related]
6. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
7. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156.
Miller P; James GW
Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):328-39. PubMed ID: 25634
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma].
Nishiyori T; Tsuchiya H; Inagaki N; Nagai H; Koda A
Nihon Yakurigaku Zasshi; 1985 Jan; 85(1):7-16. PubMed ID: 2580764
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of E-721B, an indigenous herbal combination in experimental models of immediate hypersensitivity.
Lakshmana M; Rafiq M; Sridhar BY
Indian J Physiol Pharmacol; 2001 Jul; 45(3):319-28. PubMed ID: 11881571
[TBL] [Abstract][Full Text] [Related]
11. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
12. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the specificity in pharmacological inhibition of the passive cutaneous anaphylaxis reaction in mice and rats.
Perper RJ; Oronsky AL; Blancuzzi V
J Pharmacol Exp Ther; 1975 May; 193(2):594-602. PubMed ID: 49417
[TBL] [Abstract][Full Text] [Related]
14. BL-5255. I. Activity in animal models of immediate hypersensitivity reactions.
Siminoff P; Reed FC; Schurig JE
Int Arch Allergy Appl Immunol; 1982; 67(2):101-8. PubMed ID: 6799411
[TBL] [Abstract][Full Text] [Related]
15. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic characterization of the antiallergic activity of SK&F 78729-A.
Chakrin LW; Krell RD
J Pharmacol Exp Ther; 1978 Dec; 207(3):756-66. PubMed ID: 83359
[TBL] [Abstract][Full Text] [Related]
17. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on bronchial and cutaneous allergic responses to ascaris in dogs.
Misawa M; Ohmori S; Yanaura S
Arzneimittelforschung; 1986 Nov; 36(11):1647-50. PubMed ID: 2434112
[TBL] [Abstract][Full Text] [Related]
18. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
19. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
[TBL] [Abstract][Full Text] [Related]
20. Effect of cinnarizine on IgE antibody-mediated experimental allergic reactions in guinea pigs.
Nagai H; Yamada H; Yakuo I; Inagaki N; Choi SH; Koda A; Daikoku M
Allergy; 1987 Feb; 42(2):135-40. PubMed ID: 2438961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
